The health-related quality of life among survivors with post-COVID conditions in the United States

Seyyed Sina Hejazian, Ajith Vemuri, Alireza Vafaei Sadr, et. al. PLOS, One 20(5): e0320721. https://doi.org/10.1371/journal.pone.0320721 Abstract Background Even after a mild initial SARS-CoV-2 infection, a considerable proportion of patients experience…[...]

Read More

Safety and efficacy of low dose naltrexone in a long covid cohort; an interventional pre-post study.

O'Kelly B 1,2, Vidal L 2, McHugh T 2, et. al. Brain, Behavior, & Immunity - Health, 03 Jul 2022, 24:100485, https://doi.org/10.1016/j.bbih.2022.100485 PMID: 35814187 PMCID: PMC9250701 Abstract  Background Up to 37.7% of patients experience symptoms beyond 12 weeks after…[...]

Read More